s-nitrosoglutathione has been researched along with Blood Pressure, High in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grave, K; Königshausen, E; Mori, Y; Potthoff, SA; Rump, LC; Sivritas, SH; Stamer, S; Stegbauer, J; Thieme, M; Woznowski, M | 1 |
Everett, TR; Lees, CC; Wilkinson, IB | 1 |
Abramov, AA; Arzamastsev, EV; Buriachkovskaia, LI; Chazov, EI; Dobrovol'skiĭ, AB; Dragnev, AG; Gramovich, VV; Kapel'ko, VI; Lakomkin, VL; Maksimov, GV; Masenko, VP; Rodnenkov, OV; Timoshin, AA; Vanin, AF; Vyborov, ON; Zorin, AV | 1 |
Jung, N; Lehmann, C; Roesen, R; Schömig, E; Taubert, D | 1 |
1 review(s) available for s-nitrosoglutathione and Blood Pressure, High
Article | Year |
---|---|
Pre-eclampsia: the Potential of GSNO Reductase Inhibitors.
Topics: Animals; Endothelium; Enzyme Inhibitors; Female; Humans; Hypertension; Nitric Oxide; Pre-Eclampsia; Pregnancy; S-Nitrosoglutathione | 2017 |
2 trial(s) available for s-nitrosoglutathione and Blood Pressure, High
Article | Year |
---|---|
[The study of hypotensive action of dinitrosyl-iron complex with glutathione containing drug oxacom in healthy volunteers].
Topics: Adult; Animals; Biological Availability; Blood Pressure; Drug Evaluation, Preclinical; Drug Monitoring; Glutathione; Humans; Hypertension; Hypotension; Infusions, Intravenous; Iron; Male; Nitric Oxide; Nitrogen Oxides; Rats; Rats, Wistar; S-Nitrosoglutathione; Sodium Nitrite; Therapeutic Equivalency; Therapies, Investigational; Treatment Outcome | 2011 |
Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial.
Topics: Aged; Beverages; Blood Pressure; Cacao; Candy; Diet; Dinoprost; Female; Flavonoids; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Phenols; Polyphenols; S-Nitrosoglutathione | 2007 |
1 other study(ies) available for s-nitrosoglutathione and Blood Pressure, High
Article | Year |
---|---|
Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Hypertension; Kidney; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Perfusion; Protein Kinase Inhibitors; S-Nitrosoglutathione; Systole; Vascular Remodeling | 2016 |